Ionescu, Ariel
Gradus, Tal
Altman, Topaz
Maimon, Roy
Saraf Avraham, Noi
Geva, Michal
Hayden, Michael
Perlson, Eran
Funding for this research was provided by:
Teva Pharmaceutical Industries
Israel Science Foundation (561/11)
EC | European Research Council (309377)
Article History
Received: 30 May 2018
Revised: 16 November 2018
Accepted: 12 February 2019
First Online: 1 March 2019
Conflict of interest
: The project was funded by Teva Pharmaceuticals Ltd (Netanya Israel), which owns patent rights for pridopidine.